Fraction of dbbact annotations with this term covered by the query
Fraction of annotations for the query sequences containing the term
Number of experiments associating the term to the sequence
| Exp. ID |
User ID |
Description |
Date |
Region |
Sequences |
Status |
Flag |
| 1836 | gpt-5 | Left vs right lower lobe BAL (intra-lung site differences) ( high in lower lobe of left lung compared to lower lobe of right lung in tuberculosis mycobacterium tuberculosis infection city of pittsburgh united states of america bronchoalveolar lavage macaca fascicularis biosafety level 3 facility ) | 2025-11-15 | v4 | 1 / 3 | pending | No |
| 1836 | gpt-5 | Left vs right lower lobe BAL (intra-lung site differences) ( high in lower lobe of right lung compared to lower lobe of left lung in tuberculosis mycobacterium tuberculosis infection city of pittsburgh united states of america bronchoalveolar lavage macaca fascicularis biosafety level 3 facility ) | 2025-11-15 | v4 | 1 / 3 | pending | No |
| 1836 | gpt-5 | Bronchoscope saline control (SC/SS) samples (dominant bronchoscope, control, saline, city of pittsburgh, united states of america, respiratory tract metagenome, biosafety level 3 facility) | 2025-11-15 | v4 | 1 / 8 | pending | No |
| 1836 | gpt-5 | Bronchoscope saline control (SC/SS) samples (common bronchoscope, control, saline, city of pittsburgh, united states of america, respiratory tract metagenome, biosafety level 3 facility) | 2025-11-15 | v4 | 1 / 9 | pending | No |
| 1836 | gpt-5 | Baseline timepoint samples (suffix 0 or B) (dominant lung, control, city of pittsburgh, united states of america, bronchoalveolar lavage, macaca fascicularis, biosafety level 3 facility, pre-infection) | 2025-11-15 | v4 | 1 / 14 | pending | No |
| 1836 | gpt-5 | Temporal trajectory from baseline to 4 months (dominant lung, city of pittsburgh, united states of america, bronchoalveolar lavage, macaca fascicularis, biosafety level 3 facility) | 2025-11-15 | v4 | 1 / 14 | pending | No |
| 1836 | gpt-5 | Bronchoalveolar lavage (BAL) samples (dominant tuberculosis, lung, mycobacterium tuberculosis infection, city of pittsburgh, bronchoalveolar lavage, united states of america, macaca fascicularis, biosafety level 3 facility) | 2025-11-15 | v4 | 1 / 15 | pending | No |
| 1836 | gpt-5 | Right lower lobe BAL samples (dominant tuberculosis, mycobacterium tuberculosis infection, city of pittsburgh, bronchoalveolar lavage, united states of america, macaca fascicularis, lower lobe of right lung, biosafety level 3 facility) | 2025-11-15 | v4 | 1 / 15 | pending | No |
| 1836 | gpt-5 | Month 1 post-infection samples (suffix 1 or 1B) (dominant tuberculosis, lung, mycobacterium tuberculosis infection, city of pittsburgh, bronchoalveolar lavage, united states of america, macaca fascicularis, biosafety level 3 facility, 1 month post-infection) | 2025-11-15 | v4 | 1 / 15 | pending | No |
| 1836 | gpt-5 | Month 4 post-infection samples (suffix 4 or 11/14/15 groups per cohort schema) (dominant tuberculosis, lung, mycobacterium tuberculosis infection, city of pittsburgh, bronchoalveolar lavage, united states of america, macaca fascicularis, 4 months post-infection, biosafety level 3 facility) | 2025-11-15 | v4 | 1 / 15 | pending | No |
| 1836 | gpt-5 | Oral wash (OW) samples (dominant tuberculosis, city of pittsburgh, united states of america, oral cavity, macaca fascicularis, cheek pouch, biosafety level 3 facility) | 2025-11-15 | v4 | 1 / 18 | pending | No |
| 1836 | gpt-5 | Temporal dynamics: baseline vs 1 month ( high in pre-infection control compared to tuberculosis 1 month post-infection mycobacterium tuberculosis infection in lung city of pittsburgh united states of america bronchoalveolar lavage macaca fascicularis biosafety level 3 facility ) | 2025-11-15 | v4 | 1 / 21 | pending | No |
| 1836 | gpt-5 | Temporal dynamics: baseline vs 1 month ( high in tuberculosis 1 month post-infection mycobacterium tuberculosis infection compared to pre-infection control in lung city of pittsburgh united states of america bronchoalveolar lavage macaca fascicularis biosafety level 3 facility ) | 2025-11-15 | v4 | 1 / 22 | pending | No |
| 1836 | gpt-5 | Month 1 post-infection samples (suffix 1 or 1B) (common tuberculosis, lung, mycobacterium tuberculosis infection, city of pittsburgh, bronchoalveolar lavage, united states of america, macaca fascicularis, biosafety level 3 facility, 1 month post-infection) | 2025-11-15 | v4 | 1 / 31 | pending | No |
| 1836 | gpt-5 | Baseline timepoint samples (suffix 0 or B) (common lung, control, city of pittsburgh, united states of america, bronchoalveolar lavage, macaca fascicularis, biosafety level 3 facility, pre-infection) | 2025-11-15 | v4 | 1 / 38 | pending | No |
| 1836 | gpt-5 | Temporal trajectory from baseline to 4 months (common lung, city of pittsburgh, united states of america, bronchoalveolar lavage, macaca fascicularis, biosafety level 3 facility) | 2025-11-15 | v4 | 1 / 39 | pending | No |
| 1836 | gpt-5 | Environmental/bronchoscope control vs biological samples (contamination assessment) ( high in saline bronchoscope control respiratory tract metagenome compared to tuberculosis macaca fascicularis in biosafety level 3 facility city of pittsburgh united states of america ) | 2025-11-15 | v4 | 1 / 47 | pending | No |
| 1836 | gpt-5 | Bronchoalveolar lavage (BAL) samples (common tuberculosis, lung, mycobacterium tuberculosis infection, city of pittsburgh, bronchoalveolar lavage, united states of america, macaca fascicularis, biosafety level 3 facility) | 2025-11-15 | v4 | 1 / 53 | pending | No |
| 1836 | gpt-5 | Right lower lobe BAL samples (common tuberculosis, mycobacterium tuberculosis infection, city of pittsburgh, bronchoalveolar lavage, united states of america, macaca fascicularis, lower lobe of right lung, biosafety level 3 facility) | 2025-11-15 | v4 | 1 / 55 | pending | No |
| 1836 | gpt-5 | Month 4 post-infection samples (suffix 4 or 11/14/15 groups per cohort schema) (common tuberculosis, lung, mycobacterium tuberculosis infection, city of pittsburgh, bronchoalveolar lavage, united states of america, macaca fascicularis, 4 months post-infection, biosafety level 3 facility) | 2025-11-15 | v4 | 1 / 66 | pending | No |
| 1836 | gpt-5 | Oral wash (OW) samples (common tuberculosis, city of pittsburgh, united states of america, oral cavity, macaca fascicularis, cheek pouch, biosafety level 3 facility) | 2025-11-15 | v4 | 1 / 72 | pending | No |
| 1836 | gpt-5 | Lower airway vs upper airway/oral microbiome ( high in mycobacterium tuberculosis infection bronchoalveolar lavage compared to oral cavity cheek pouch in tuberculosis city of pittsburgh united states of america macaca fascicularis biosafety level 3 facility ) | 2025-11-15 | v4 | 1 / 126 | pending | No |
| 1836 | gpt-5 | Lower airway vs upper airway/oral microbiome ( high in oral cavity cheek pouch compared to mycobacterium tuberculosis infection bronchoalveolar lavage in tuberculosis city of pittsburgh united states of america macaca fascicularis biosafety level 3 facility ) | 2025-11-15 | v4 | 1 / 149 | pending | No |
| 1836 | gpt-5 | Environmental/bronchoscope control vs biological samples (contamination assessment) ( high in tuberculosis macaca fascicularis compared to saline bronchoscope control respiratory tract metagenome in biosafety level 3 facility city of pittsburgh united states of america ) | 2025-11-15 | v4 | 1 / 346 | pending | No |
